Page last updated: 2024-10-26

doxylamine and Pneumoconiosis

doxylamine has been researched along with Pneumoconiosis in 1 studies

Doxylamine: Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in PARKINSONISM.

Pneumoconiosis: A diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kagan, G1
Rose, R1

Trials

1 trial available for doxylamine and Pneumoconiosis

ArticleYear
Double-blind trial of a long-acting bronchodilator preparation ("Nethaprin Dospan") in bronchospastic disease.
    Current medical research and opinion, 1976, Volume: 4, Issue:6

    Topics: Asthma; Bronchial Spasm; Bronchiectasis; Bronchitis; Bronchodilator Agents; Child; Clinical Trials a

1976